Feb 17, 2026 09:15AM
Feb 17, 2026 09:15AM
Feb 11, 2026 09:16AM
Feb 11, 2026 09:15AM
Feb 9, 2026 09:15AM
Feb 9, 2026 09:15AM
Jan 8, 2026 08:46AM Biofrontera locks databases for actinic keratosis and acne studies
Jan 8, 2026 08:45AM
Dec 18, 2025 08:45AM
Dec 18, 2025 08:45AM
Dec 4, 2025 09:00AM
Dec 4, 2025 09:00AM
Dec 2, 2025 08:45AM
Dec 2, 2025 08:45AM Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz®-PDT
Nov 13, 2025 08:15AM
Nov 7, 2025 08:00AM
Nov 7, 2025 08:00AM
Sep 16, 2025 10:30AM
Sep 16, 2025 10:30AM
Sep 16, 2025 10:30AM
Aug 25, 2025 08:27AM Biofrontera completes Phase 2b acne trial enrollment for Ameluz gel
Aug 25, 2025 08:25AM
Aug 11, 2025 04:25PM
Aug 11, 2025 04:25PM
Jun 30, 2025 08:00AM
Jun 3, 2025 02:30PM
Jun 3, 2025 02:30PM
May 15, 2025 12:17PM Biofrontera (BFRI) Announces New Patent Protection on Ameluz until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz
May 15, 2025 12:17PM
Mar 21, 2025 08:00AM
Mar 18, 2025 09:30AM
Jan 8, 2025 09:51AM
Jan 8, 2025 09:50AM
Dec 23, 2024 09:31AM
Dec 23, 2024 09:30AM Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market
Nov 13, 2024 05:15PM
Oct 31, 2024 10:33AM
Oct 31, 2024 10:32AM
Oct 14, 2024 10:30AM
Oct 14, 2024 10:30AM
Oct 7, 2024 02:04PM
Oct 7, 2024 08:45AM Biofrontera (BFRI): FDA Approves Use of Up To Three Tubes of Ameluz Topical Gel, 10% In One Treatment
Oct 7, 2024 08:45AM
Aug 14, 2024 04:30PM
Jun 24, 2024 11:55AM
Jun 24, 2024 08:30AM
May 15, 2024 04:45PM
Mar 15, 2024 08:12PM
Mar 15, 2024 04:56PM Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
Mar 5, 2024 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All